Zymosense

Menu
Contact
Contact

Privacy and Safety

Global Privacy Policy for
Zymosense, Inc.

Effective Date: August 2021
Last Updated: March 2025

Zymosense is committed to protecting personal data in accordance with global privacy laws, including but not limited to:

  • EU GDPR
  • US CCPA/CPRA

This policy outlines how we collect, use, store, and protect personal data across jurisdictions. Zymosense does not collect data from consumers or the general public.

We only process personal data from professional contacts, clients, and collaborators via inquiry forms and research engagements.

Scope:

This policy applies to:

  • Personal data collected via our website and forms.
  • Data processed for internal and client scientific research.
  • Use of cookies and artificial intelligence tools.
  • Cross-border data transfers and international collaborations.
Types of Personal Data We Collect

We may collect:

  • Name, email, phone number
  • Organization or affiliation
  • Inquiry or project details

We do not collect sensitive personal data unless required for a research project and with appropriate safeguards.

Use of Artificial Intelligence

We may use AI tools to:

  • Analyze scientific datasets
  • Assist in data curation and improve communication
  • Conduct research


We do not use AI for profiling, automated decision-making, or consumer targeting.

Cookies and Tracking Technologies

We use cookies to:

  • Improve website functionality
  • Analyze traffic and usage patterns
Data Sharing and Retention

Data may be shared with:

  • Authorized employees or contractors
  • Cloud or IT service providers (with appropriate safeguards)
  • Clients as a function of the services delivered

We retain personal data only as long as necessary:

  • Authorized employees or contractors
  • Cloud or IT service providers (with appropriate safeguards)
  • Clients as a function of the services delivered
Changes to This Policy

We may update this policy periodically. Changes will be posted on our website with the updated effective date.

Zymosense Carbon
Nanotube Safety Policy

Effective Date: August 2021
Last Updated: March 2025

Overview

At Zymosense, safety is our highest priority. While we do not manufacture carbon
nanotubes (CNTs), we use them in solution-based applications sourced from certified
manufacturers. This policy outlines the risks, regulatory guidance—including NIOSH
recommendations—and the protocols we follow to ensure safe handling and disposal.

Material Sourcing
  • All CNTs are obtained from certified manufacturers in hazard-compliant
    packaging.
  • Zymosense does not synthesize CNTs on-site.
Understanding the Risks
  • Inhalation Risk: Dry CNTs can aerosolize and pose respiratory hazards.
  • Dermal Contact: CNTs may penetrate skin if contaminated materials are
    mishandled.
  • Environmental Impact: CNTs are biopersistent and require controlled disposal.
NIOSH Recommendations

Zymosense aligns with NIOSH guidance for CNT safety:

  •  
  • Exposure Limit:
    Maintain airborne CNT concentrations below 1 µg/m³ (elemental carbon as
    respirable mass), measured as an 8-hour time-weighted average.
  • Hierarchy of Controls:
    • Engineering Controls: Use enclosures, local exhaust ventilation, and
      HEPA filtration.
    • Administrative Controls: Written nanomaterial safety program, risk
      assessments, and continuous improvement.
    • PPE: NIOSH-approved respirators for aerosolization risk, nitrile gloves, lab
      coats, and eye protection.
  • Handling & Disposal:
    • Treat CNTs and contaminated materials as hazardous waste.
    • Use wet cleaning methods; avoid dry sweeping or compressed air.
  • Exposure Monitoring:
    • Conduct workplace sampling using NIOSH-approved methods.
    • Maintain exposure logs and review regularly.
  • Training:
    • Annual CNT safety training for all personnel.
    • Ensure access to SDS and SOPs.
Zymosense Safety Protocols

Engineering Controls

  • CNT work is performed in ventilated biosafety cabinets or fume hoods.
  • HEPA filtration in waste handling areas.

Handling Procedures

  • CNT solutions handled using low-splash techniques.
  • Single-use items (pipette tips, wipes) disposed of immediately in sealed
    hazardous waste containers.
  • Surfaces cleaned with wet methods to prevent drying and aerosolization.

We retain personal data only as long as necessary:

  • All CNT-contaminated materials treated as hazardous nanomaterial waste.
  • Stored in clearly labeled, sealed containers and disposed of via certified
    hazardous waste services.
Spill Response
  • Clean spills with wet wipes and HEPA-filtered vacuums.
  • Dispose of cleanup materials as hazardous waste.
  • Log and review all incidents.
Commitment to Safety

Zymosense is committed to:

  • Staying informed on emerging CNT safety research.
  • Updating protocols in line with NIOSH standards and regulatory changes.
  • Collaborating with industry and academic partners to refine safety practices.